HalfLifeDBEvidence before certainty.

U-47700 evidence profile

The human record in this source set is a fatal mixed-intoxication case.

Category: synthetic-opioid · Updated: August 7, 2026

Sources and model notes are maintained by . This page is educational, not clinical guidance. Corrections: admin@halflifedb.co.

Model statusNo curve publishedCurrent sources do not support one defensible human input
Evidence boundarySource note onlyNo animal, forensic, mixture, or proxy value is presented as a human half-life
Model scopeNot modeledThe profile explains what the available records can and cannot establish
References2Linked studies, labels, reviews, or identity records described below

U-47700: evidence and interpretation notes

Why HalfLifeDB does not plot U-47700

The human record in this source set is a fatal mixed-intoxication case. Case concentrations can inform forensic interpretation, but they cannot establish a typical human half-life for U-47700.

What each source contributes

  • PubChem: U-47700. This identity record confirms names and compound identity and does not supply a human half-life.
  • Mixed intoxication by the synthetic opioid U-47700 and the benzodiazepine flubromazepam with lethal outcome: Pharmacokinetic data. This case record documents an observed clinical or forensic exposure and cannot define a controlled population value.

For U-47700, the decision to withhold a curve turns on the limits visible in Mixed intoxication by the synthetic opioid U-47700 and the benzodiazepine flubromazepam with lethal outcome: Pharmacokinetic data. This case record documents an observed clinical or forensic exposure, but it cannot define a controlled population value.

What evidence would change the page

The next useful evidence for U-47700 would be a direct human pharmacokinetic study with a defined exposure context and sufficient late sampling. Without that, converting Mixed intoxication by the synthetic opioid U-47700 and the benzodiazepine flubromazepam with lethal outcome: Pharmacokinetic data into a first-order midpoint would overstate what its design can support.

InterpretationCategory context and evidence limits

synthetic opioid context

Synthetic opioid pages often require careful evidence labeling because potency, toxicology risk, and pharmacokinetic evidence quality can vary widely across compounds.

  • Half-life is not a potency or overdose-risk measure.
  • Some entries may rely on limited or indirect data.
  • Public-health and toxicology context should be separated from the simple curve.
EvidenceSource trail and model decision

Sources and evidence context

A linked record is not automatically proof of the displayed value. Study, labeling, review, and compound identity sources serve different purposes; notes below identify limitations when they are known.

1 PubMed0 PMC0 DailyMed1 PubChem
  1. Identity record PubChem Compound Summary: U-47700.
    Compound identity and naming record. It supplies chemistry context, not independent numerical support for the model.
  2. Research abstract PubMed: Mixed intoxication by the synthetic opioid U-47700 and the benzodiazepine flubromazepam with lethal outcome: Pharmacokinetic data.
    Forensic or clinical case evidence. It documents an observed exposure but does not define typical controlled human pharmacokinetics.
BoundariesWhat this page cannot answer and where to continue

What this page does not answer

  • It does not estimate impairment, intoxication, or fitness to drive.
  • It does not predict urine, blood, saliva, or hair test results.
  • It does not model repeated exposure, tolerance, withdrawal, or interactions.
  • It does not replace clinician, pharmacist, toxicologist, or emergency guidance.

Continue with context

Read the medical disclaimer, methodology, and research standards before using the model for comparison.